Ebola Virus-Specific Neutralizing Antibody Persists at High Levels in Survivors 2 Years After Resolution of Disease in a Sierra Leonean Cohort.
Bond NG, Shore KR, Engel EJ, Coonan EE, Al-Hasan F, Gbakie MA, Kamara FK, Kanneh L, Momoh M, Kanneh IM, Sandi JD, Elliott D, Ficenec SC, Smira AR, Fischer WA, Wohl DA, Robinson JE, Shaffer JG, Garry RF, Samuels RJ, Grant DS, Schieffelin JS.
Bond NG, et al.
J Infect Dis. 2024 May 27:jiae155. doi: 10.1093/infdis/jiae155. Online ahead of print.
J Infect Dis. 2024.
PMID: 38801652